Sentence examples for blocker with the from inspiring English sources

To compare a new bronchial blocker, the Cohen blocker, with the Arndt blocker and a left double-lumen tube (DLT).

Telmisartan is a specific AT1 receptor blocker with the strongest binding affinity to AT1 receptor among various ARBs [ 9] and is a partial agonist of peroxisome proliferator-activated receptor- γ (PPAR- γ) [ 10].

The study compares the effects of telmisartan, an angiotensin receptor blocker with the longest half-life and greatest brain penetration of its class, and perindropil, an angiotensin-converting enzyme inhibitor that reduces dementia from stroke, but has not been shown to improve nonvascular dementia.

The above data support the hypothesis that adrenaline exerts its effect on the pmr locus via the reversible interaction of the β-adrenergic blocker with the BasS membrane sensor in a manner similar to the interaction of adrenaline with QseC in E. coli.

While the 7-foot-1 McIlvaine had proven to be a skilled shot-blocker with the Washington Bullets, he had shown little else to justify such a contract.

Here, by studying the interactions of blockers with the miniature potassium channel Kcv, we identified a single point mutation in a residue that forms intimate contacts with the permeant ions at site 4 in the selectivity filter, T63S, and that affects channel blockade by both the divalent ion barium and the small molecule blocker amantadine.

The INVEST International Verapamil-Trandolaprill study) study, including more than 22,500 hypertensive patients with coronary impairment, compared a nondihidropiridinic calcium channel blocker and a β-blocker, with the opportunity to add an ACE inhibitor or a diuretic in order to reach the target.

Most of the cnidarian peptides are known to be potassium channel blockers, with the exception of metridin.

The β-blockers with the most potent antineuroblastoma properties in vitro were mixed α/ β-blocker carvedilol, selective β1-blocker nebivolol and, to a lesser extent, non-selective β-blocker propranolol.

Finally, in the mid-90s and onwards, several clinical trials comparing the effectiveness of thiazides and β blockers with the newer drug classes began [ 5- 11].

Analyses were undertaken to compare all patients receiving β-blockers with the controls and also for patients subdivided into those receiving and those not receiving additional BPLM.